Cas no for 1051375-16-6,GSK1349572 ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Post Sourcing Request Exhibition

Home > CAS No. Inquiry > 1051375-16-6

[CAS Name] GSK1349572

[Formula] C20H19F2N3O5

Search Products Post Sourcing Request

[CAS Name]GSK1349572
[Alias]GSK1349572;(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;S/GSK1349572 (GSK1349572);Dolutegravir;GSK1349572(dolutegravir)
[Number]1051375-16-6
[EINECS]
[Formula]C20H19F2N3O5
[Molecular weight]

1051375-16-6 Suppliers

Company

Main Products

Hangzhou Sartort Biopharma Co., Ltd	Welcome to search www.sartort.com, Sartort would appreciate the opportunity to work with your company by providing the nice quality, service,and technical support with competitive pricing.	Send Inquiry
Nanjing Fred Technology Co., Ltd.	Purity:≥98%	Send Inquiry
Shenzhen Haorui Pharmatech Co., Ltd.	Dolutegravir is an HIV-1 integrase inhibitor that blocks the strand transfer step of the integration of the viral genome into the host cell (INSTI). The effect of this drug has no homology in human host cells, which gives it excellent tolerability and minimal toxicity. Dolutegravir was developed by ViiV Healthcare and FDA-approved on August 12, 2013. On November 21, 2017, dolutegravir, in combination with rilpivirine, was approved as part of the first complete treatment regimen with only two drugs for the treatment of adults with HIV-1 named Juluca.	Send Inquiry

Previous page 1 2 3 Next page

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Intellectual Property; Media Partners

PharmaSources Customer Service